36 related articles for article (PubMed ID: 34504846)
1. Corrigendum: Editorial: MSC-derived exosomes in tissue regeneration.
Chen XM; Wang X; Hou Z
Front Cell Dev Biol; 2023; 11():1302578. PubMed ID: 37854068
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: Potential of cellular therapy for ALS: current strategies and future prospects.
Lin TJ; Cheng KC; Wu LY; Lai WY; Ling TY; Kuo YC; Huang YH
Front Cell Dev Biol; 2023; 11():1292681. PubMed ID: 37795262
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Single-cell RNA sequencing reveals the role of phosphorylation-related genes in hepatocellular carcinoma stem cells.
Yao F; Zhan Y; Li C; Lu Y; Chen J; Deng J; Wu Z; Li Q; Song Y; Chen B; Chen J; Tian K; Pu Z; Ni Y; Mou L
Front Cell Dev Biol; 2023; 11():1045260. PubMed ID: 37954208
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: A TNFR2-specific TNF fusion protein with improved
Gamboa Vargas J; Wagner J; Shaikh H; Lang I; Medler J; Anany M; Steinfatt T; Peña Mosca J; Haack S; Dahlhoff J; Büttner-Herold M; Graf C; Viera EA; Einsele H; Wajant H; Beilhack A
Front Immunol; 2023; 14():1352525. PubMed ID: 38164131
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: miR-212/132-enriched extracellular vesicles promote differentiation of induced pluripotent stem cells into pancreatic beta cells.
Bai C; Ren Q; Liu H; Li X; Guan W; Gao Y
Front Cell Dev Biol; 2023; 11():1258178. PubMed ID: 37601100
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Lipid metabolism and tumor immunotherapy.
Wang Y; Guo Z; Isah AD; Chen S; Ren Y; Cai H
Front Cell Dev Biol; 2024; 12():1349379. PubMed ID: 38344750
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma.
Liu S; Zhou H; Wang G; Lian X
Front Cell Dev Biol; 2024; 12():1396267. PubMed ID: 38633107
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Clinical and immunological effects of p53-targeting vaccines.
Zhou S; Fan C; Zeng Z; Young KH; Li Y
Front Cell Dev Biol; 2023; 11():1267661. PubMed ID: 37601114
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Editorial: Metabolic modulation of cellular function.
Kakhlon O; Saada A; Escriba PV
Front Cell Dev Biol; 2024; 12():1403128. PubMed ID: 38665431
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Endothelial RGS12 governs angiogenesis in inflammatory arthritis by controlling cilia formation and elongation via MYCBP2 signaling" [Cell Insight 1 (2022) 100055].
Yuan G; Yang ST; Yang S
Cell Insight; 2023 Dec; 2(6):100102. PubMed ID: 37965246
[TBL] [Abstract][Full Text] [Related]
11. Retraction: Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy.
Frontiers Editorial Office
Front Cell Dev Biol; 2023; 11():1285267. PubMed ID: 37731816
[TBL] [Abstract][Full Text] [Related]
12. Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma.
Zhao H; Chen Y; Shen P; Gong L
Front Cell Dev Biol; 2021; 9():713569. PubMed ID: 34513843
[TBL] [Abstract][Full Text] [Related]
13. Targeting TNFR2 in Cancer: All Roads Lead to Rome.
Bai J; Ding B; Li H
Front Immunol; 2022; 13():844931. PubMed ID: 35251045
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells Overexpressing ACE2 Favorably Ameliorate LPS-Induced Inflammatory Injury in Mammary Epithelial Cells.
Yan S; Ye P; Aleem MT; Chen X; Xie N; Zhang Y
Front Immunol; 2021; 12():796744. PubMed ID: 35095873
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties.
Beldi G; Bahiraii S; Lezin C; Nouri Barkestani M; Abdelgawad ME; Uzan G; Naserian S
Front Cell Dev Biol; 2021; 9():753407. PubMed ID: 34504846
[TBL] [Abstract][Full Text] [Related]
16. TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties.
Beldi G; Bahiraii S; Lezin C; Nouri Barkestani M; Abdelgawad ME; Uzan G; Naserian S
Front Cell Dev Biol; 2020; 8():596831. PubMed ID: 33344453
[TBL] [Abstract][Full Text] [Related]
17. TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.
Beldi G; Khosravi M; Abdelgawad ME; Salomon BL; Uzan G; Haouas H; Naserian S
Stem Cell Res Ther; 2020 Jul; 11(1):281. PubMed ID: 32669116
[TBL] [Abstract][Full Text] [Related]
18. TNFα-TNFR2 signaling pathway in control of the neural stem/progenitor cell immunosuppressive effect: Different experimental approaches to assess this hypothetical mechanism behind their immunological function.
Shamdani S; Uzan G; Naserian S
Stem Cell Res Ther; 2020 Jul; 11(1):307. PubMed ID: 32698887
[TBL] [Abstract][Full Text] [Related]
19. The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration.
Harrell CR; Djonov V; Volarevic V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804369
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
